PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
18980982-8	2008	A single ABT-888 dose (3 or 12.5 mg/kg) reduced intratumor PAR levels by >95%.	2,2'-azino-di-(3-ethylbenzothiazoline)-6-sulfonic acid	9-12	jumping translocation breakpoint	Homo sapiens	59-62	
19823047-7	2009	CONCLUSIONS: ABT-888 hits its therapeutic target by significantly reducing PAR levels and the ratio of PAR to PARP-1 in human tumor cells detected by immunohistochemistry.	2,2'-azino-di-(3-ethylbenzothiazoline)-6-sulfonic acid	13-16	jumping translocation breakpoint	Homo sapiens	75-78	
19823047-7	2009	CONCLUSIONS: ABT-888 hits its therapeutic target by significantly reducing PAR levels and the ratio of PAR to PARP-1 in human tumor cells detected by immunohistochemistry.	2,2'-azino-di-(3-ethylbenzothiazoline)-6-sulfonic acid	13-16	jumping translocation breakpoint	Homo sapiens	103-106	
18980982-9	2008	ABT-888 (1.56-25 mg/kg) significantly decreased PAR levels at 2 h post-dosing.	2,2'-azino-di-(3-ethylbenzothiazoline)-6-sulfonic acid	0-3	jumping translocation breakpoint	Homo sapiens	48-51